Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Fetal Tissue, Stem Cells & Bioethics

Ethical Adult Stem Cell Treatments Result in “Profound Improvement” for MS Patients

British media are reporting a significant development in the use of ethical, non-embryonic stem cells to treat patients with multiple sclerosis (MS) and, perhaps, other auto-immune diseases.

 

Auto-immune diseases are caused by an abnormal immune response which causes the immune system to attack and destroy healthy tissues in a person’s own body.  Such diseases include Type 1 diabetes, rheumatoid arthritis, scleroderma and lupus, among many others. While the exact cause is not known, many researchers believe multiple sclerosis occurs when a person’s immune system attacks tissue of the brain and spinal cord, resulting in severe pain, impaired movement and in the most extreme cases, death.

 

The experimental treatment for MS consists of two steps.  First, doctors use chemotherapy to knock-out the patients’ faulty immune system and then, in effect, “reboot” the system with a massive injection of stem cells derived from the patients’ own blood.

 

Professor Basil Sharrack, a consultant neurologist on the study, described the results as “miraculous.” “This isn’t a word I would use lightly, but we have seen profound neurological improvements,” he said.

 

According to the media reports, patients regained their ability to walk, run and dance, including some patients who for years had been confined to wheelchairs.

 

But this is not the first time this method using non-embryonic stem cells has been used to successfully treat patients with auto-immune diseases.

 

In 2009 Dr. Richard Burt, head of the Division of -Immunotherapy and Autoimmune Diseases at Northwestern University’s Feinberg School of Medicine used this technique to treat MS patients with very positive results.  In addition to MS, Dr. Burt went on to use this method to treat patients with lupus, scleroderma, and even Type 1 diabetes, all with positive results.

 

British researchers have now used this method pioneered by Dr. Burt to successfully treat patients with MS, showing once again that when it comes to actually providing real therapeutic benefits for patients, the ethical, non-embryonic stem cells are leading the way.

 

Gene Tarne is Senior Analyst for the Charlotte Lozier Institute.

Latest Posts

May 13, 2024 New Study Reveals FDA Relied on Cherrypicked Data to Approve Dangerous Mail-Order Abortion Drugs New Study Reveals FDA Relied on Cherrypicked Data to Approve Dangerous Mail-Order Abortion Drugs May 9, 2024 Abortion Reporting: Oklahoma (2023) April 30, 2024 Gestational Limits on Abortion in the United States Compared to International Norms (April 2024)

You Might Also Be Interested In

A Fact-Free Campaign Against Parents and Unborn Children in Alabama

April 22, 2024
ClosePlease login
Lozier Institute Amicus Brief in Support of Ecuador Law Limiting Abortion

Lozier Institute Amicus Brief in Support of Ecuador Law Limiting Abortion

charlotte-lozier-institute Charlotte Lozier Institute
February 21, 2024
ClosePlease login

Public Comment: Lozier Institute on CDC’s Notice of Proposed Modifications to Assisted Reproductive Technology Program Reporting

charlotte-lozier-institute Charlotte Lozier Institute
February 21, 2024
ClosePlease login

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image